U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H11N3O3
Molecular Weight 209.2019
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2',3'-DIDEHYDRO-2',3'-DIDEOXYCYTIDINE

SMILES

NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)C=C2

InChI

InChIKey=OOBICGOWICFMIX-POYBYMJQSA-N
InChI=1S/C9H11N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h1-4,6,8,13H,5H2,(H2,10,11,14)/t6-,8+/m0/s1

HIDE SMILES / InChI

Molecular Formula C9H11N3O3
Molecular Weight 209.2019
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
3'-Carbon-substituted pyrimidine nucleosides having a 2',3'-dideoxy and 2',3'-didehydro-2',3'-dideoxy structure: synthesis and antiviral evaluation.
2006
In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase.
2005-03
Synthesis, structure-activity relationships, and drug resistance of beta-d-3'-fluoro-2',3'-unsaturated nucleosides as anti-HIV Agents.
2004-06-17
Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro.
1996-04-26
Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture.
1994-06
Potential prodrug derivatives of 2',3'-didehydro-2',3'-dideoxynucleosides. Preparations and antiviral activities.
1992-07-24
Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
1992-01-22
Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.
1991-10-01
Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
1991-05
Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis.
1991-02
Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.
1990-05-21
Comparative studies of 2',3'-didehydro-2',3'-dideoxythymidine (D4T) with other pyrimidine nucleoside analogues.
1990
Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells.
1988-10-01
The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species.
1988-03-01
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro.
1987-10
Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.
1987-09-01
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.
1987-08
The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
1987-07
Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
1987-06
Antiviral activity of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2',3'-didehydrocytidine) against human immunodeficiency virus in vitro.
1987-02-01
Synthesis and antiviral activity of various 3'-azido, 3'-amino, 2',3'-unsaturated, and 2',3'-dideoxy analogues of pyrimidine deoxyribonucleosides against retroviruses.
1987-02
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.
1987-01-15
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:27:36 GMT 2025
Edited
by admin
on Mon Mar 31 21:27:36 GMT 2025
Record UNII
CI9X00489L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2',3'-DIDEHYDRO-2',3'-DIDEOXYCYTIDINE
Systematic Name English
ZALCITABINE RELATED COMPOUND A
USP   USP-RS  
Preferred Name English
ZALCITABINE RELATED COMPOUND A [USP-RS]
Common Name English
ZALCITABINE RELATED COMPOUND A [USP IMPURITY]
Common Name English
Code System Code Type Description
RS_ITEM_NUM
1724317
Created by admin on Mon Mar 31 21:27:36 GMT 2025 , Edited by admin on Mon Mar 31 21:27:36 GMT 2025
PRIMARY
EPA CompTox
DTXSID30225784
Created by admin on Mon Mar 31 21:27:36 GMT 2025 , Edited by admin on Mon Mar 31 21:27:36 GMT 2025
PRIMARY
CAS
7481-88-1
Created by admin on Mon Mar 31 21:27:36 GMT 2025 , Edited by admin on Mon Mar 31 21:27:36 GMT 2025
PRIMARY
FDA UNII
CI9X00489L
Created by admin on Mon Mar 31 21:27:36 GMT 2025 , Edited by admin on Mon Mar 31 21:27:36 GMT 2025
PRIMARY
PUBCHEM
64683
Created by admin on Mon Mar 31 21:27:36 GMT 2025 , Edited by admin on Mon Mar 31 21:27:36 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY